Novartis Pulling Out All The Stops To Amp Up Entresto Sales

The company has set a sales goal of $200m for Entresto in 2016, not an enormous amount for a drug that is expected to eventually be a multi-billion dollar seller, but ambitious given its slow first quarter start.